Combine searches by placing the search numbers in the top search box and pressing the search button. An example search might look like (#1 or #2) and (#3 or #4)
Latest & greatest articles for breast cancer screening
The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on breast cancer screening or other clinical topics then use Trip today.
This page lists the very latest high quality evidence on breast cancer screening and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.
What is Trip?
Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.
Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.
As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.
For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via firstname.lastname@example.org
) recommends against publicly funding screeningbreast magnetic resonance imaging (MRI) as an adjunct to screening mammography for women who are at less than high risk for breastcancer and who have no personal history of breastcancer Final publication URL Indexing Status Subject indexing assigned by CRD MeSH BreastNeoplasms; Humans; Magnetic Resonance Imaging; Mammography Language Published English Country of organisation Canada Province or state Ontario English summary An English language summary (...) Magnetic resonance imaging as an adjunct to mammography for breastcancerscreening in women at less than high risk for breastcancer: OHTAC recommendation Magnetic resonance imaging as an adjunct to mammography for breastcancerscreening in women at less than high risk for breastcancer: OHTAC recommendation Magnetic resonance imaging as an adjunct to mammography for breastcancerscreening in women at less than high risk for breastcancer: OHTAC recommendation Health Quality Ontario Record
Magnetic Resonance Imaging as an Adjunct to Mammography for BreastCancerScreening in Women at Less Than High Risk for BreastCancer Health Technology Assessment - Health Quality Ontario (HQO) Let's make our health system healthier Open Menu Quick Links Search Search A A A Evidence to Improve Care Share: Health Technology Assessment To continuously improve the quality of health care in Ontario, we use established scientific methods to analyze evidence and develop assessments of new
Breast-CancerTumor Size, Overdiagnosis, and Mammography Screening Effectiveness. The goal of screening mammography is to detect small malignanttumors before they grow large enough to cause symptoms. Effective screening should therefore lead to the detection of a greater number of small tumors, followed by fewer large tumors over time.We used data from the Surveillance, Epidemiology, and End Results (SEER) program, 1975 through 2012, to calculate the tumor-size distribution and size-specific (...) observed per 100,000 women). Assuming that the underlying disease burden was stable, only 30 of the 162 additional small tumors per 100,000 women that were diagnosed were expected to progress to become large, which implied that the remaining 132 cases of cancer per 100,000 women were overdiagnosed (i.e., cases of cancer were detected on screening that never would have led to clinical symptoms). The potential of screening to lower breastcancer mortality is reflected in the declining incidence of larger
Improvement in risk prediction, early detection and prevention of breastcancer in the NHS BreastScreening Programme and family history clinics: a dual cohort study Improvement in risk prediction, early detection and prevention of breastcancer in the NHS BreastScreening Programme and family history clinics:a dual cohort study Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could
. Although women suffered marked anxiety from experiencing false-positive mammography tests and loss of confidence from false- negative results, these feelings generally did not diminish women's belief in the value of mammography screening. In many cases, the experiences reinforced the importance of risk reduction as well as screening. Final publication URL Indexing Status Subject indexing assigned by CRD MeSH BreastNeoplasms; Diagnostic Errors; Early Detection of Cancer; Female; Humans Language (...) Women's experiences of inaccurate breastcancerscreening results: a systematic review and qualitative meta-synthesis Women's experiences of inaccurate breastcancerscreening results: a systematic review and qualitative meta-synthesis Women's experiences of inaccurate breastcancerscreening results: a systematic review and qualitative meta-synthesis Health Quality Ontario Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA
breast ultrasound as an adjunct to screening mammography in women at average risk for breastcancer. Final publication URL Indexing Status Subject indexing assigned by CRD MeSH BreastNeoplasms; Early Detection of Cancer; High-Energy Shock Waves; Humans; Mammography Language Published English Country of organisation Canada Province or state Ontario English summary An English language summary is available. Address for correspondence Evidence Development and Standards, Health Quality Ontario, 130 Bloor (...) Ultrasound as an adjunct to mammography for breastcancerscreening: OHTAC recommendation Ultrasound as an adjunct to mammography for breastcancerscreening: OHTAC recommendation Ultrasound as an adjunct to mammography for breastcancerscreening: OHTAC recommendation Health Quality Ontario Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation
breastcancer, there is low-quality evidence that screening with mammography and adjunct ultrasound detects additional cases of disease, with improved sensitivity compared to mammography alone. Screening with adjunct ultrasound also increases the number of false-positive findings and subsequent biopsy recommendations. It is unclear if the use of screeningbreast ultrasound as an adjunct to mammography will reduce breastcancer–related mortality among high-risk women. The annual cost burden of using (...) adjunct ultrasound to screen high-risk women who cannot receive MRI in Ontario would be small. Final publication URL Indexing Status Subject indexing assigned by CRD MeSH BreastNeoplasms; Early Detection of Cancer; High-Energy Shock Waves; Humans; Mammography; Technology Assessment, Biomedical Language Published English Country of organisation Canada Province or state Ontario English summary An English language summary is available. Address for correspondence Evidence Development and Standards
Tailoring BreastCancerScreening Intervals by Breast Density and Risk for Women Aged 50 Years or Older: Collaborative Modeling of Screening Outcomes. Biennial screening is generally recommended for average-risk women aged 50 to 74 years, but tailored screening may provide greater benefits.To estimate outcomes for various screening intervals after age 50 years based on breast density and risk for breast cancer.Collaborative simulation modeling using national incidence, breast density (...) , and screening performance data.United States.Women aged 50 years or older with various combinations of breast density and relative risk (RR) of 1.0, 1.3, 2.0, or 4.0.Annual, biennial, or triennial digital mammography screening from ages 50 to 74 years (vs. no screening) and ages 65 to 74 years (vs. biennial digital mammography from ages 50 to 64 years).Lifetime breastcancer deaths, life expectancy and quality-adjusted life-years (QALYs), false-positive mammograms, benign biopsy results, overdiagnosis, cost
BreastCancerScreening Options for Women with Dense Breast Tissue Proven Best Choices: BreastCancerScreening - ICER Menu Close Other ICER Proven Best Choices: BreastCancerScreening A patient guide for choosing supplemental breastcancerscreening options for women with dense breasts. or EMAIL SIGNUP Stay up-to-date on the latest news from ICER. CONTACT US Institute for Clinical and Economic Review Two Liberty Square, Ninth Floor, Boston, MA 02109 (617) 528-4013 STAY CONNECTED | To ensure
also recognized that the population of high-risk women is very small, with a high burden of disease, and that this technology may be particularly helpful in women who have a contraindication to MRI, the current standard of care. Ultrasound as an Adjunct to Mammography for BreastCancerScreening: OHTAC Recommendation. July 2016; pp. 1–4 2 Decision Determinants for Ultrasound as an Adjunct to Mammography for BreastCancerScreening Decision Criteria Subcriteria Decision Determinants Considerations (...) of the disease. Need How large is the need for this health technology/intervention? Women at average risk for developing breastcancer currently only receive mammography screening for breastcancer. Mammography screening is not perfect, and therefore a number of these women may have their cancers missed by mammography due to factors such as dense breasts and younger age. Currently, 1.15 million women in Ontario aged 50 to 74 years are screened with mammography annually. Women at high risk for breastcancer
BreastCancerScreening and Prevention. This issue provides a clinical overview of breastcancerscreening and prevention, focusing on risk assessment, screening, prevention, and practice improvement. The content of In the Clinic is drawn from the clinical information and education resources of the American College of Physicians (ACP), including MKSAP (Medical Knowledge and Self-Assessment Program). Annals of Internal Medicine editors develop In the Clinic in collaboration with the ACP's
Effect of Using the Same vs Different Order for Second Readings of Screening Mammograms on Rates of BreastCancer Detection: A Randomized Clinical Trial. Interpreting screening mammograms is a difficult repetitive task that can result in missed cancers and false-positive recalls. In the United Kingdom, 2 film readers independently evaluate each mammogram to search for signs of cancer and examine digital mammograms in batches. However, a vigilance decrement (reduced detection rate with time (...) on task) has been observed in similar settings.To determine the effect of changing the order for the second film reader of batches of screening mammograms on rates of breastcancer detection.A multicenter, double-blind, cluster randomized clinical trial conducted at 46 specialized breastscreening centers from the National Health Service BreastScreening Program in England for 1 year (all between December 20, 2012, and November 3, 2014). Three hundred sixty readers participated (mean, 7.8 readers per
were compliant with the recommendation and received follow-up care. One abnormal follow-up mammogram/ultrasound result was negative on biopsy. One woman with an aggressive phyllodes tumor had a mastectomy within 60 days. Multimodal education about breastcancerscreening maximized delivery of women's health services in a low-tech rural setting.The addition of opportunistic breastcancer education and screening to a cervical cancerscreening event resulted in high uptake of services at low (...) Opportunistic BreastCancer Education and Screening in Rural Honduras In Honduras, the breastcancer burden is high, and access to women's health services is low. This project tested the connection of community-based breastcancer detection with clinical diagnosis and treatment in a tightly linked and quickly facilitated format.The Norris Cotton Cancer Center at Dartmouth College partnered with the Honduran cancer hospital La Liga Contra el Cancer to expand a cervical cancerscreening program
Cost-Effectiveness of Three Rounds of Mammography BreastCancerScreening in Iranian Women Breastcancer is the most common cancer in Iranian women as is worldwide. Mammography screening has been introduced as a beneficial method for reducing mortality and morbidity of this disease.We developed an analytical model to assess the cost effectiveness of an organized mammography screening program in Iran for early detection of the breast cancer.This study is an economic evaluation of mammography (...) screening program among Iranian woman aged 40 - 70 years. A decision tree and Markov model were applied to estimate total quality adjusted life years (QALY) and lifetime costs.The results revealed that the incremental cost effectiveness ratio (ICER) of mammography screening in Iranian women in the first round was Int. $ 37,350 per QALY gained. The model showed that the ICER in the second and third rounds of screening program were Int. $ 141,641 and Int. $ 389,148 respectively.Study results identified
Radiation-Induced BreastCancer Incidence and Mortality From Digital Mammography Screening: A Modeling Study. Estimates of risk for radiation-induced breastcancer from mammography screening have not considered variation in dose exposure or diagnostic work-up after abnormal screening results.To estimate distributions of radiation-induced breastcancer incidence and mortality from digital mammography screening while considering exposure from screening and diagnostic mammography and dose (...) variation among women.2 simulation-modeling approaches.U.S. population.Women aged 40 to 74 years.Annual or biennial digital mammography screening from age 40, 45, or 50 years until age 74 years.Lifetime breastcancer deaths averted (benefits) and radiation-induced breastcancer incidence and mortality (harms) per 100,000 women screened.Annual screening of 100,000 women aged 40 to 74 years was projected to induce 125 breastcancer cases (95% CI, 88 to 178) leading to 16 deaths (CI, 11 to 23), relative
Collaborative Modeling of the Benefits and Harms Associated With Different U.S. BreastCancerScreening Strategies. Controversy persists about optimal mammography screening strategies.To evaluate screening outcomes, taking into account advances in mammography and treatment of breast cancer.Collaboration of 6 simulation models using national data on incidence, digital mammography performance, treatment effects, and other-cause mortality.United States.Average-risk U.S. female population (...) and subgroups with varying risk, breast density, or comorbidity.Eight strategies differing by age at which screening starts (40, 45, or 50 years) and screening interval (annual, biennial, and hybrid [annual for women in their 40s and biennial thereafter]). All strategies assumed 100% adherence and stopped at age 74 years.Benefits (breastcancer-specific mortality reduction, breastcancer deaths averted, life-years, and quality-adjusted life-years); number of mammograms used; harms (false-positive results
Screening for BreastCancer: U.S. Preventive Services Task Force Recommendation Statement. Update of the 2009 U.S. Preventive Services Task Force (USPSTF) recommendation on screening for breast cancer.The USPSTF reviewed the evidence on the following: effectiveness of breastcancerscreening in reducing breastcancer-specific and all-cause mortality, as well as the incidence of advanced breastcancer and treatment-related morbidity; harms of breastcancerscreening; test performance (...) characteristics of digital breast tomosynthesis as a primary screening strategy; and adjunctive screening in women with increased breast density. In addition, the USPSTF reviewed comparative decision models on optimal starting and stopping ages and intervals for screening mammography; how breast density, breastcancer risk, and comorbidity level affect the balance of benefit and harms of screening mammography; and the number of radiation-induced breastcancer cases and deaths associated with different
Intern Med 0372351 0003-4819 AIM IM Ann Intern Med. 2016 Feb 16;164(4):268-78 26757021 Breast anatomy & histology BreastNeoplasms diagnosis Early Detection of Cancer methods Female Humans Mass Screening methods 2016 1 13 6 0 2016 1 13 6 0 2016 6 24 6 0 ppublish 26757338 2480758 10.7326/M15-2977 PMC4829104 NIHMS775646 Cancer Epidemiol Biomarkers Prev. 2010 May;19(5):1219-28 20406961 Int J Cancer. 2015 Oct 1;137(7):1729-38 25820931 J Natl Cancer Inst. 2016 Apr;108(4). pii: djv367. doi: 10.1093/jnci (...) Supplemental BreastCancerScreening in Women with Dense Breasts Should be Offered with Simultaneous Collection of Outcomes Data 26757338 2016 06 23 2018 12 02 1539-3704 164 4 2016 Feb 16 Annals of internal medicine Ann. Intern. Med. Supplemental BreastCancerScreening in Women With Dense Breasts Should Be Offered With Simultaneous Collection of Outcomes Data. 299-300 10.7326/M15-2977 Berg Wendie A WA eng R01 CA187593 CA NCI NIH HHS United States Editorial Comment 2016 01 12 United States Ann
. ((adenoma* or neoplasia or cancer* or neoplasm* or tumo?r* or carcinoma* or adenocarcinoma*) and (breast or cervical or cervix or colon or colorectal or crc)).ti,ab. 2 or 3 1 and 4 colonography, computed tomographic/ or colonoscopy/ or endoscopy, gastrointestinal/ or sigmoidoscopy/ or ((occult blood.ti,ab. or occult blood/) and (feces/ or (faeces or fecal or faecal or colorectal).ti,ab.)) or (enema/ and barium sulfate/) mammography/ or mammogra*.ti,ab. (colonography or colonoscop* or fobt (...) and uncontrolled vocabularies and search software. Following are the search strategies used in Medline. Databases : Medline mass screening/ or multiphasic screening/ or (screen or screened or screening).ti,ab. or "early detection of cancer"/ (neoplasms/ or breastneoplasms/ or colorectal neoplasms/ or uterine cervical neoplasms/ or carcinoma, ductal, breast/ or "hereditary breast and ovarian cancer syndrome"/ or inflammatory breastneoplasms/ or colonic neoplasms/ or rectal neoplasms/) and (di or pc).fs
of a woman's lifetime. ACS selected the Duke University Evidence Synthesis Group to conduct an independent systematic evidence review after a response to a request for proposals, and commissioned the BreastCancer Surveillance Consortium (BCSC) to update previously published analyses related to the screening interval and outcomes. The ACS Surveillance and Health Services Research Program provided supplementary data on disease burden using data from the Surveillance, Epidemiology, and End Results (SEER (...) Screening for BreastCancer in Women at Average Risk* Screening for BreastCancer in Women at Average Risk | National Guideline Clearinghouse success fail JUL Aug 12 2018 2019 30 Sep 2016 - 13 Jul 2018 COLLECTED BY Organization: Formed in 2009, the Archive Team (not to be confused with the archive.org Archive-It Team) is a rogue archivist collective dedicated to saving copies of rapidly dying or deleted websites for the sake of history and digital heritage. The group is 100% composed